Loading…
The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells
Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly...
Saved in:
Published in: | European journal of immunology 2012-11, Vol.42 (11), p.2889-2900 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3 |
container_end_page | 2900 |
container_issue | 11 |
container_start_page | 2889 |
container_title | European journal of immunology |
container_volume | 42 |
creator | Zhan, Yifan Vega‐Ramos, Javier Carrington, Emma M. Villadangos, Jose A. Lew, Andrew M. Xu, Yuekang |
description | Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly examined. Here, we report that GM‐CSF alters Flt3L‐induced DC development. When BM cells were cultured with both Flt3L and GM‐CSF, few CD8+ equivalent DCs or plasmacytoid DCs developed compared to cultures supplemented with Flt3L alone. The disappearance of these two cell subsets in GM‐CSF + Flt3L culture was not a result of simple inhibition of their development, but a diversion of the original differentiation trajectory to form a new cell population. As a consequence, both DC progeny and their functions were altered. The effect of GM‐CSF on DC subset development was confirmed in vivo. First, the CD8+ DC numbers were increased under GM‐CSF deficiency (when either GM‐CSF or its receptor was ablated). Second, this population was decreased under GM‐CSF hyperexpression (by transgenesis or by Listeria infection). Our finding that GM‐CSF dominantly changes the regulation of DC development in vitro and in vivo has important implications for inflammatory diseases or GM‐CSF therapy. |
doi_str_mv | 10.1002/eji.201242477 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1443378446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2824341081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3</originalsourceid><addsrcrecordid>eNqF0c9u1DAQBnALgehSOHJFlrj00LSe8cROjmjVlqKiHihnK38mIksSL3YC2lsfoc_YJ8HVlh44wMkH__xpPJ8Qb0GdgFJ4ypv-BBUgIVn7TKwgR8gICJ6LlVJAGZaFOhCvYtwopUqTly_FAWKhjClhJdzNN5b91A3VOFazDzvZ7Gb_vZ_4WF58vr-9W385P5bVMHOIck625Z88-O3I01wN0i9z40eWvpPjEtKrdD-1oZ_7RjY8DPG1eNFVQ-Q3j-eh-Hp-drP-mF1dX1yuP1xlDWkDWQ6lbtnYUmPNigwWYAlVYcoaauhM23QFaW6A8haLrrJtl9eK0BaMdQ6sD8XRPncb_I-F4-zGPj5MUE3sl-iASGtbEJn_07RMm-cGbaLv_6Ibv4QpfSSp0hJoUJhUtldN8DEG7tw29GMVdg6UeyjJpZLcU0nJv3tMXeqR2yf9p5UEcA9-9QPv_p3mzj5dIgHo39V2muc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1197413102</pqid></control><display><type>article</type><title>The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Zhan, Yifan ; Vega‐Ramos, Javier ; Carrington, Emma M. ; Villadangos, Jose A. ; Lew, Andrew M. ; Xu, Yuekang</creator><creatorcontrib>Zhan, Yifan ; Vega‐Ramos, Javier ; Carrington, Emma M. ; Villadangos, Jose A. ; Lew, Andrew M. ; Xu, Yuekang</creatorcontrib><description>Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly examined. Here, we report that GM‐CSF alters Flt3L‐induced DC development. When BM cells were cultured with both Flt3L and GM‐CSF, few CD8+ equivalent DCs or plasmacytoid DCs developed compared to cultures supplemented with Flt3L alone. The disappearance of these two cell subsets in GM‐CSF + Flt3L culture was not a result of simple inhibition of their development, but a diversion of the original differentiation trajectory to form a new cell population. As a consequence, both DC progeny and their functions were altered. The effect of GM‐CSF on DC subset development was confirmed in vivo. First, the CD8+ DC numbers were increased under GM‐CSF deficiency (when either GM‐CSF or its receptor was ablated). Second, this population was decreased under GM‐CSF hyperexpression (by transgenesis or by Listeria infection). Our finding that GM‐CSF dominantly changes the regulation of DC development in vitro and in vivo has important implications for inflammatory diseases or GM‐CSF therapy.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.201242477</identifier><identifier>PMID: 22806691</identifier><identifier>CODEN: EJIMAF</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Animals ; Antigen Presentation - immunology ; Cell Differentiation - immunology ; Cytokines ; Dendritic Cells - cytology ; Dendritic Cells - immunology ; Dendritic cells and differentiation ; Flow Cytometry ; Flt3L ; fms-Like Tyrosine Kinase 3 - immunology ; GM‐CSF ; Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology ; Inflammation - immunology ; Inflammation - pathology ; Interleukin-10 - immunology ; Interleukin-12 - immunology ; Membrane Proteins - immunology ; Membrane Proteins - pharmacology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mice, Transgenic ; Reactive Oxygen Species - immunology ; Recombinant Proteins - pharmacology ; Tumor Necrosis Factor-alpha - immunology</subject><ispartof>European journal of immunology, 2012-11, Vol.42 (11), p.2889-2900</ispartof><rights>2012 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.</rights><rights>2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3</citedby><cites>FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22806691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhan, Yifan</creatorcontrib><creatorcontrib>Vega‐Ramos, Javier</creatorcontrib><creatorcontrib>Carrington, Emma M.</creatorcontrib><creatorcontrib>Villadangos, Jose A.</creatorcontrib><creatorcontrib>Lew, Andrew M.</creatorcontrib><creatorcontrib>Xu, Yuekang</creatorcontrib><title>The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly examined. Here, we report that GM‐CSF alters Flt3L‐induced DC development. When BM cells were cultured with both Flt3L and GM‐CSF, few CD8+ equivalent DCs or plasmacytoid DCs developed compared to cultures supplemented with Flt3L alone. The disappearance of these two cell subsets in GM‐CSF + Flt3L culture was not a result of simple inhibition of their development, but a diversion of the original differentiation trajectory to form a new cell population. As a consequence, both DC progeny and their functions were altered. The effect of GM‐CSF on DC subset development was confirmed in vivo. First, the CD8+ DC numbers were increased under GM‐CSF deficiency (when either GM‐CSF or its receptor was ablated). Second, this population was decreased under GM‐CSF hyperexpression (by transgenesis or by Listeria infection). Our finding that GM‐CSF dominantly changes the regulation of DC development in vitro and in vivo has important implications for inflammatory diseases or GM‐CSF therapy.</description><subject>Animals</subject><subject>Antigen Presentation - immunology</subject><subject>Cell Differentiation - immunology</subject><subject>Cytokines</subject><subject>Dendritic Cells - cytology</subject><subject>Dendritic Cells - immunology</subject><subject>Dendritic cells and differentiation</subject><subject>Flow Cytometry</subject><subject>Flt3L</subject><subject>fms-Like Tyrosine Kinase 3 - immunology</subject><subject>GM‐CSF</subject><subject>Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology</subject><subject>Inflammation - immunology</subject><subject>Inflammation - pathology</subject><subject>Interleukin-10 - immunology</subject><subject>Interleukin-12 - immunology</subject><subject>Membrane Proteins - immunology</subject><subject>Membrane Proteins - pharmacology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Reactive Oxygen Species - immunology</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqF0c9u1DAQBnALgehSOHJFlrj00LSe8cROjmjVlqKiHihnK38mIksSL3YC2lsfoc_YJ8HVlh44wMkH__xpPJ8Qb0GdgFJ4ypv-BBUgIVn7TKwgR8gICJ6LlVJAGZaFOhCvYtwopUqTly_FAWKhjClhJdzNN5b91A3VOFazDzvZ7Gb_vZ_4WF58vr-9W385P5bVMHOIck625Z88-O3I01wN0i9z40eWvpPjEtKrdD-1oZ_7RjY8DPG1eNFVQ-Q3j-eh-Hp-drP-mF1dX1yuP1xlDWkDWQ6lbtnYUmPNigwWYAlVYcoaauhM23QFaW6A8haLrrJtl9eK0BaMdQ6sD8XRPncb_I-F4-zGPj5MUE3sl-iASGtbEJn_07RMm-cGbaLv_6Ibv4QpfSSp0hJoUJhUtldN8DEG7tw29GMVdg6UeyjJpZLcU0nJv3tMXeqR2yf9p5UEcA9-9QPv_p3mzj5dIgHo39V2muc</recordid><startdate>201211</startdate><enddate>201211</enddate><creator>Zhan, Yifan</creator><creator>Vega‐Ramos, Javier</creator><creator>Carrington, Emma M.</creator><creator>Villadangos, Jose A.</creator><creator>Lew, Andrew M.</creator><creator>Xu, Yuekang</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201211</creationdate><title>The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells</title><author>Zhan, Yifan ; Vega‐Ramos, Javier ; Carrington, Emma M. ; Villadangos, Jose A. ; Lew, Andrew M. ; Xu, Yuekang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Antigen Presentation - immunology</topic><topic>Cell Differentiation - immunology</topic><topic>Cytokines</topic><topic>Dendritic Cells - cytology</topic><topic>Dendritic Cells - immunology</topic><topic>Dendritic cells and differentiation</topic><topic>Flow Cytometry</topic><topic>Flt3L</topic><topic>fms-Like Tyrosine Kinase 3 - immunology</topic><topic>GM‐CSF</topic><topic>Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology</topic><topic>Inflammation - immunology</topic><topic>Inflammation - pathology</topic><topic>Interleukin-10 - immunology</topic><topic>Interleukin-12 - immunology</topic><topic>Membrane Proteins - immunology</topic><topic>Membrane Proteins - pharmacology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Reactive Oxygen Species - immunology</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhan, Yifan</creatorcontrib><creatorcontrib>Vega‐Ramos, Javier</creatorcontrib><creatorcontrib>Carrington, Emma M.</creatorcontrib><creatorcontrib>Villadangos, Jose A.</creatorcontrib><creatorcontrib>Lew, Andrew M.</creatorcontrib><creatorcontrib>Xu, Yuekang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhan, Yifan</au><au>Vega‐Ramos, Javier</au><au>Carrington, Emma M.</au><au>Villadangos, Jose A.</au><au>Lew, Andrew M.</au><au>Xu, Yuekang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2012-11</date><risdate>2012</risdate><volume>42</volume><issue>11</issue><spage>2889</spage><epage>2900</epage><pages>2889-2900</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><coden>EJIMAF</coden><abstract>Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly examined. Here, we report that GM‐CSF alters Flt3L‐induced DC development. When BM cells were cultured with both Flt3L and GM‐CSF, few CD8+ equivalent DCs or plasmacytoid DCs developed compared to cultures supplemented with Flt3L alone. The disappearance of these two cell subsets in GM‐CSF + Flt3L culture was not a result of simple inhibition of their development, but a diversion of the original differentiation trajectory to form a new cell population. As a consequence, both DC progeny and their functions were altered. The effect of GM‐CSF on DC subset development was confirmed in vivo. First, the CD8+ DC numbers were increased under GM‐CSF deficiency (when either GM‐CSF or its receptor was ablated). Second, this population was decreased under GM‐CSF hyperexpression (by transgenesis or by Listeria infection). Our finding that GM‐CSF dominantly changes the regulation of DC development in vitro and in vivo has important implications for inflammatory diseases or GM‐CSF therapy.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>22806691</pmid><doi>10.1002/eji.201242477</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2980 |
ispartof | European journal of immunology, 2012-11, Vol.42 (11), p.2889-2900 |
issn | 0014-2980 1521-4141 |
language | eng |
recordid | cdi_proquest_miscellaneous_1443378446 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Animals Antigen Presentation - immunology Cell Differentiation - immunology Cytokines Dendritic Cells - cytology Dendritic Cells - immunology Dendritic cells and differentiation Flow Cytometry Flt3L fms-Like Tyrosine Kinase 3 - immunology GM‐CSF Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology Inflammation - immunology Inflammation - pathology Interleukin-10 - immunology Interleukin-12 - immunology Membrane Proteins - immunology Membrane Proteins - pharmacology Mice Mice, Inbred C57BL Mice, Knockout Mice, Transgenic Reactive Oxygen Species - immunology Recombinant Proteins - pharmacology Tumor Necrosis Factor-alpha - immunology |
title | The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A34%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20inflammatory%20cytokine,%20GM%E2%80%90CSF,%20alters%20the%20developmental%20outcome%20of%20murine%20dendritic%20cells&rft.jtitle=European%20journal%20of%20immunology&rft.au=Zhan,%20Yifan&rft.date=2012-11&rft.volume=42&rft.issue=11&rft.spage=2889&rft.epage=2900&rft.pages=2889-2900&rft.issn=0014-2980&rft.eissn=1521-4141&rft.coden=EJIMAF&rft_id=info:doi/10.1002/eji.201242477&rft_dat=%3Cproquest_cross%3E2824341081%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1197413102&rft_id=info:pmid/22806691&rfr_iscdi=true |